Have a personal or library account? Click to login
Betulinic acid and its ionic derivatives impaired growth of prostate cancer cells without induction of GRP78 and CHOP Cover

Betulinic acid and its ionic derivatives impaired growth of prostate cancer cells without induction of GRP78 and CHOP

Current Issues in Pharmacy and Medical Sciences
Volume 35 (2022): Issue 4 (December 2022)
By: Alexus Williams,  Keshawna Smith,  Zarin Bhuiyan,  Jasmine Phillips,  Hua Zhao and  Takayuki Nitta  
Open Access
|Feb 2023

Metrics

DOI: https://doi.org/10.2478/cipms-2022-0030 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 163 - 168
Submitted on: Mar 15, 2022
|
Accepted on: Sep 25, 2022
|
Published on: Feb 9, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
prostate cancer,
cell viability,
GRP78,
ethnicity,
ER stress,
betulinic acid
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2023 Alexus Williams, Keshawna Smith, Zarin Bhuiyan, Jasmine Phillips, Hua Zhao, Takayuki Nitta, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 35 (2022): Issue 4 (December 2022)Next article